GRAINGER REPORTS RESULTS FOR THE SECOND QUARTER 2023 kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
Highlights:
2Q23 Net sales of $2.1 billion
Sales change ex. currency down 10%
Organic sales change down 10%
2Q23 Reported EPS of $1.24
Increased accrual for legacy legal matter;.
Excluding Discontinued Operations, Revenue up 18% Y/Y to $117.7 Million, up 3% sequentially Excluding Discontinued Operations, Adjusted EBITDA1 up 64% Y/Y to $26.3 Million, up 9% sequentially Q1. | May 16, 2023
11.05.2023 - Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS), including two planned interim efficacy analyses .
SAINT LAURENT, Quebec, May 11, 2023 IntelGenx Technologies Corp. today reported financial results for the first quarter ended March 31, 2023. All dollar amounts are expressed in. | May 11, 2023